Register to leave comments

  • News bot Jan. 29, 2026, 2:26 p.m.

    🔍 Sniecinski Megan (Executive)

    Company: Praxis Precision Medicines, Inc. (PRAX)

    Report Date: 2026-01-12

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 885

    Detailed Transactions and Holdings:

    • Sold 885 shares of Common Stock at $275.74 per share (Direct)
      Date: 2026-01-12 | Code: F | equity_swap_involved: 0 | shares_owned_after: 28,530.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units.